Kelyniam Global Inc. (OTC: KLYG), a medical device manufacturing firm in Canton, Conn., is buying Cranston Holdings LLC, in a deal that is expected to add stereolithography and rapid prototyping expertise to Kelyniam.

Terms of the acquisition, per a news release from Kelyniam today, include an equity trade for assets and revenues of Florida-based Cranston Holdings, which had 2010 revenue of about $600,000. Cranston Holdings has proprietary software, linked to ISO compliance, that Kelyniam president and CEO James Ketner said would become part of Kelyniam’s intellectual property portfolio.

SOURCE